Vitamin D: The Most Important Supplement Most People Get Wrong

At a Glance

The Most Misunderstood Molecule in Medicine

What I tell my patients on the first visit, almost without exception: get your vitamin D level tested. In our hospital’s 30+ years of clinical practice, with patients from over 90 countries, vitamin D deficiency has been the most widespread, most consequential and most poorly managed nutrient deficiency we encounter.

Many physicians still think of vitamin D as a bone vitamin. It is a secosteroid hormone that modulates the expression of over 1,000 human genes, roughly 5% of the entire human genome. It regulates calcium metabolism, and it also governs immune function, inflammatory response, mood, insulin sensitivity, cardiovascular health and antimicrobial defense. Calling vitamin D “a bone vitamin” is like calling the internet “an email system.”

One of the genes regulated through the vitamin D receptor (VDR) is klotho, an anti-aging protein whose promoter contains direct VDR binding sites, making vitamin D sufficiency one of the most actionable levers for preserving klotho levels as you age.

In my view the evidence is strong for deficiency and bone, and disappointing in large prevention trials such as VITAL.

Vitamin D Is Not a Vitamin

Let me be precise about the biochemistry, because it matters for understanding dosing.

When ultraviolet B radiation hits 7-dehydrocholesterol in your skin, it produces cholecalciferol (vitamin D3). Strictly speaking this is a photosynthetic product your body manufactures, like a hormone; the term “vitamin” is a historical accident.

The liver then converts cholecalciferol to 25-hydroxyvitamin D (25(OH)D, or calcidiol), which is what blood tests measure. The kidneys (and many other tissues) convert that to 1,25-dihydroxyvitamin D (calcitriol), the biologically active form that binds to the vitamin D receptor (VDR).

An underappreciated factor in this two-step conversion is boron, a trace mineral shown in animal and human studies to support efficient conversion of 25-OH vitamin D to active calcitriol. Patients who supplement with adequate D3 yet fail to respond clinically may have impaired conversion; ensuring sufficient boron intake alongside the standard cofactors (K2, magnesium) is a low-risk, evidence-supported step. Boron’s role in vitamin D metabolism, testosterone, and inflammation is covered in our dedicated guide.

The VDR is found in virtually every tissue in the human body: immune cells, brain, heart, muscle, gut, pancreas, prostate, breast, and bone. That is why vitamin D influences so many systems: it acts as a master regulatory hormone far beyond its role in calcium absorption.

Beyond Bone Health: What Vitamin D Does

Immune Modulation

This is where the evidence is strongest and most clinically relevant, particularly for the patients I treat.

Vitamin D is essential for both innate and adaptive immune function:

Innate immunity: Vitamin D upregulates the expression of cathelicidin (LL-37) and defensins, antimicrobial peptides that are your body’s first line of defense against bacteria, viruses, and fungi. LL-37 is particularly important: it directly kills pathogens by disrupting their cell membranes, it breaks down bacterial biofilms, and it modulates the inflammatory response to prevent excessive tissue damage.

In patients with chronic infections (Lyme disease, recurrent respiratory infections, chronic sinusitis) I consistently find suboptimal vitamin D levels. When we optimize vitamin D to 60-80 ng/ml, LL-37 production increases measurably and clinical outcomes improve. LL-37 upregulation may be one of the most important mechanisms by which vitamin D reduces infection susceptibility.

Adaptive immunity: Vitamin D modulates T-cell differentiation, promoting regulatory T-cells (Tregs) that prevent autoimmune overactivation while maintaining the capacity to fight infections. It suppresses Th17 responses (associated with autoimmunity and excessive inflammation) and promotes Th2 and Treg responses that restore immune balance.

This is why vitamin D deficiency is consistently associated with autoimmune conditions: multiple sclerosis, type 1 diabetes, rheumatoid arthritis, inflammatory bowel disease. The epidemiological association is strong, and the mechanistic pathway through VDR-mediated T-cell regulation provides a plausible explanation.

Clinical validation: The VITAL trial (25,871 participants) showed that vitamin D supplementation reduced the risk of autoimmune disease by 22% over 5 years. This was a randomized, placebo-controlled trial published in the BMJ. That is strong evidence.

Mood and Neuropsychiatric Function

The VDR is expressed throughout the brain, particularly in areas involved in mood regulation: the hippocampus, prefrontal cortex and hypothalamus. Vitamin D influences serotonin synthesis through transcriptional regulation of tryptophan hydroxylase 2 (TPH2), the rate-limiting enzyme for brain serotonin production.

Clinical data consistently shows an association between low vitamin D and depression. A meta-analysis by Anglin et al. (2013) demonstrated that low vitamin D levels were associated with a significantly increased risk of depression. Supplementation trials have shown mixed but generally positive results, particularly when baseline levels were deficient.

In my practice, I see the relationship clearly: patients with serum 25(OH)D below 30 ng/ml frequently report depressive symptoms, brain fog and fatigue. Optimization to 60-80 ng/ml often produces meaningful improvement. Vitamin D is still not an antidepressant, and mood disorders need a full assessment and treatment.

How vitamin D regulates microglial inflammation, serotonin synthesis and dopamine circuits, and its relevance in schizophrenia, autism and cognitive decline, is covered in our dedicated article on Vitamin D as a Neuroimmune Signal in Psychiatry.

Metabolic Health

Vitamin D deficiency is associated with insulin resistance, metabolic syndrome, and type 2 diabetes. The mechanism involves VDR-mediated regulation of insulin secretion in pancreatic beta cells and insulin sensitivity in target tissues. Observational data is consistent and strong. Interventional data is more mixed, but recent larger trials (D2d trial) suggest meaningful effects in prediabetic populations.

Cancer Risk Reduction

This is where I must grade the evidence carefully. Observational studies consistently show inverse associations between vitamin D levels and colorectal, breast, prostate, and other cancers. The biological mechanisms are plausible: vitamin D promotes cell differentiation, apoptosis, and anti-proliferative signaling through VDR-mediated gene regulation.

However, the major RCTs (VITAL, ViDA) have shown modest or null effects on cancer incidence as a primary outcome. Post-hoc analyses and studies that account for baseline vitamin D levels and achieved serum concentrations show more promising results. The Lappe et al. (2017) trial found that vitamin D plus calcium reduced all-cancer risk by 30% in postmenopausal women when baseline 25(OH)D was below 30 ng/ml.

My assessment: the evidence supports maintaining optimal vitamin D levels for cancer risk reduction, but it does not support using vitamin D as a cancer treatment. The distinction matters.

The Optimal Level Debate

On target levels, conventional practice and the evidence diverge most.

What Most Labs Say

Standard laboratory reference ranges typically define:

• Deficient: below 20 ng/ml (50 nmol/L)
• Insufficient: 20-29 ng/ml (50-72 nmol/L)
• Sufficient: 30-100 ng/ml (75-250 nmol/L)

What the Evidence Supports

The 30 ng/ml threshold was set mainly for bone metabolism, as the level at which PTH (parathyroid hormone) begins to rise, indicating insufficient calcium absorption. But vitamin D does far more than regulate calcium.

Research consistently suggests that many of vitamin D’s benefits beyond bone (immune modulation, mood support, cancer risk reduction) require levels well above 30 ng/ml:

• LL-37 antimicrobial peptide expression reaches optimal levels at approximately 40-60 ng/ml.
• Autoimmune disease risk continues to decrease with levels up to 50-60 ng/ml in epidemiological studies.
• Parathyroid hormone suppression is maximized at approximately 40 ng/ml.
• All-cause mortality in large meta-analyses shows a U-shaped curve with the lowest risk at approximately 40-60 ng/ml.

Based on the totality of evidence and my clinical experience, I target 60-80 ng/ml (150-200 nmol/L) in my patients. In my reading, that is the range where most of the evidence points to optimal function across multiple organ systems.

Is this controversial? Yes. The 2011 Endocrine Society guideline suggested ≥30 ng/mL; its 2024 guideline no longer recommends routine testing or a target level for healthy adults and suggests empiric supplementation only for ages 1-18, ≥75, pregnancy and prediabetes [4]. The associations above come mainly from observational data, which cannot show that raising levels causes the benefit.

Why Most People Are Deficient

In our clinical experience, consistent with published prevalence data, the majority of patients who walk through our door are vitamin D deficient or insufficient. The reasons are straightforward:

1. Latitude. Anyone living above 35°N latitude (most of Europe, northern United States, Canada) cannot produce adequate vitamin D from sun exposure for 4-6 months of the year. The sun angle is too low for UVB rays to reach the skin effectively.

2. Indoor lifestyle. Even in summer, most people spend 90% of their time indoors. Office workers, hospital patients and children in school get little meaningful sun exposure.

3. Sunscreen. SPF 30 blocks approximately 97% of UVB radiation. Sunscreen is important for skin cancer prevention, but it effectively eliminates vitamin D synthesis. This is a genuine public health tension with no perfect solution.

4. Skin pigmentation. Melanin is a natural sunscreen. People with darker skin require 3-5 times more sun exposure to produce the same amount of vitamin D as people with lighter skin. This is a significant factor in the disproportionate vitamin D deficiency seen in dark-skinned populations living at high latitudes.

5. Age. The capacity for cutaneous vitamin D synthesis declines with age. A 70-year-old produces approximately 25% of the vitamin D that a 20-year-old produces from the same sun exposure.

6. Obesity. Vitamin D is fat-soluble and sequesters in adipose tissue. People with higher body fat require substantially more vitamin D to achieve the same serum levels. This is clinically important and frequently overlooked in dosing.

7. Dietary inadequacy. Natural dietary sources of vitamin D are limited: fatty fish, egg yolks, liver. Fortified foods provide modest amounts (typically 400 IU per serving). It is virtually impossible to achieve optimal levels through diet alone.

Dosing: The Evidence-Based Approach

For informational purposes only — this summarises doses used in research and practice; it is not a prescription or individual medical advice.

The Body Weight Principle

This is a point most physicians and most supplement labels get wrong. Vitamin D dosing should be based on body weight, not on a one-size-fits-all recommendation.

The 2011 Endocrine Society guideline (since replaced) recommended:

• Adults with deficiency: 6,000 IU daily for 8 weeks to achieve levels above 30 ng/ml, then 1,500-2,000 IU daily for maintenance.
• Obese adults: 2-3x the standard dose.

The 2024 guideline replaced this with a narrower recommendation (see above) [4]. When I coach patients through dosing, I use a more nuanced approach based on published pharmacokinetic data:

These doses are higher than the RDA (600-800 IU), which was set to prevent rickets rather than to achieve optimal serum levels. The RDA is a minimum to prevent deficiency disease.

Form Matters

Vitamin D3 (cholecalciferol) is significantly more effective than D2 (ergocalciferol) at raising and maintaining serum 25(OH)D levels. Always use D3. This is settled science.

Vitamin D should be taken with a fat-containing meal for optimal absorption (it is fat-soluble). Taking it on an empty stomach reduces absorption by approximately 50%.

Testing Frequency

At minimum, test 25(OH)D twice yearly:

• Once in late winter (February-March) when levels are lowest
• Once in late summer (August-September) when levels are highest

This gives you your trough and peak. Adjust dosing so your trough does not drop below 50 ng/ml. For patients beginning supplementation or adjusting doses, I test every 8-12 weeks until stable.

The Cofactors: K2 and Magnesium

This is where most vitamin D supplementation protocols fail. Vitamin D does not work in isolation. It requires cofactors, and the two most important are vitamin K2 and magnesium.

Vitamin K2 (Menaquinone-7)

Vitamin D increases intestinal calcium absorption. Without adequate vitamin K2, that calcium can deposit in soft tissues (arterial walls, kidneys, joints) rather than in bone.

Vitamin K2 activates two critical proteins:

• Osteocalcin: directs calcium into bone matrix.
• Matrix Gla Protein (MGP): prevents calcium deposition in soft tissue and arterial walls.

Without K2, high-dose vitamin D supplementation could theoretically increase cardiovascular calcification risk. With K2, calcium goes where it should (bone) and stays out of where it should not (arteries).

Dosing: 100-200 mcg of MK-7 daily when taking vitamin D. The MK-7 form has the longest half-life and most consistent evidence. For a full clinical breakdown of MK-4 vs MK-7, the cardiovascular calcification evidence, and arterial stiffness trial data, see our complete physician guide to vitamin K2.

Magnesium

Magnesium is required for the enzymatic conversion of vitamin D to its active form. Specifically:

• The liver enzyme CYP2R1, which converts D3 to 25(OH)D, is magnesium-dependent.
• The kidney enzyme CYP27B1, which converts 25(OH)D to active 1,25(OH)2D, is magnesium-dependent.

If you are magnesium-deficient, as most people are (see our magnesium guide), your body cannot efficiently activate the vitamin D you are taking. This is one reason why some patients supplement vitamin D without seeing their serum levels rise proportionally.

Dosing: 200-400 mg of elemental magnesium daily (glycinate or threonate form preferred; our magnesium article explains why).

Safety and Toxicity

Vitamin D toxicity is real but rare and requires sustained intake well above therapeutic doses. The primary concern is hypercalcemia (elevated blood calcium), which can cause nausea, kidney stones, cardiac arrhythmias, and in severe cases, renal failure.

Key safety points:

• Toxicity typically occurs at serum levels above 150 ng/ml sustained over time. Our target of 60-80 ng/ml has a substantial safety margin.
• The lowest observed adverse effect level (LOAEL) in published case reports is generally associated with daily intakes exceeding 40,000 IU for extended periods, or single massive doses.
• At doses of 4,000-10,000 IU daily, toxicity is rare in adults, but high doses are not risk-free. The 2011 Endocrine Society guideline set 10,000 IU daily as the tolerable upper limit for adults and suggested ≥30 ng/mL; its 2024 guideline no longer recommends routine testing or a target level for healthy adults and suggests empiric supplementation only for ages 1-18, ≥75, pregnancy and prediabetes [4]. Long-term high doses should be supervised.
• Monitoring is essential. Test 25(OH)D and serum calcium periodically, particularly when initiating high-dose supplementation.
• Certain conditions increase risk: granulomatous diseases (sarcoidosis), lymphoma, and primary hyperparathyroidism can cause abnormal vitamin D metabolism and increased hypercalcemia risk. These patients need closer monitoring.

Who Needs the Most Attention?

Based on published data and clinical experience, the following populations are at highest risk for significant deficiency and stand to benefit most from optimization:

• Chronic infection patients (Lyme, post-COVID, recurrent infections): immune function depends on adequate vitamin D for LL-37 production and T-cell regulation
• Autoimmune patients: the VITAL trial showed a 22% reduction in autoimmune disease with supplementation
• People with darker skin at high latitudes: up to 80% deficiency rates in some populations
• Obese individuals: require 2-3x standard doses due to adipose sequestration
• Elderly adults: reduced synthesis capacity, increased fall and fracture risk
• Patients on medications that deplete vitamin D: anticonvulsants, glucocorticoids, rifampin, cholestyramine
• Anyone living above 35°N latitude: that includes most of Europe and the northern United States

The Bottom Line

Vitamin D is a hormone that most humans are deficient in, because our biology evolved for equatorial sun exposure and our lifestyle is indoor, high-latitude and sunscreen-protected. The evidence for its role in immune function, mood, metabolic health and disease prevention is strong, supported by large randomized trials, meta-analyses and decades of mechanistic research.

Optimal levels are 60-80 ng/ml, not the conventional “sufficient at 30.” Dosing should be based on body weight. Cofactors K2 and magnesium are non-negotiable. Testing twice yearly is the minimum.

In my clinical practice, vitamin D optimization is the first thing I address in nearly every patient. It is inexpensive, safe at appropriate doses, well-studied, and the single most impactful supplement for the greatest number of people. Get tested. Get your level to 60-80 ng/ml. Take your K2 and magnesium.

Clinical Perspective: Dr. med. univ. Julian Douwes

For informational purposes only — this summarises doses used in research and practice; it is not a prescription or individual medical advice.

The dose I discuss with the patients I coach is not the RDA, and it is not even close. For a typical 80 kg adult with a starting level of 20 ng/mL, the usual regimen is 10,000 IU of vitamin D3 daily for the first eight weeks alongside 200 mcg of vitamin K2 (MK-7) and 400 mg of magnesium glycinate, then a retest and a maintenance dose that keeps the level between 60-80 ng/mL, which is usually 5,000-7,000 IU daily. The RDA of 600-800 IU was designed to prevent rickets in children. It is inadequate for reaching the serum levels discussed above.

This reflects my clinical experience and professional opinion. It is not a substitute for individual medical advice.

Related Reading

• All Vitamin D Articles
• When to Take Supplements: The Complete Timing Guide
• Chronic Fatigue Syndrome: A Physician’s Complete Guide
• LL-37 and Vitamin D: The Immune Connection